​

Funding Round

Series A - Great Bay Bio

Series A - Great Bay Bio

Investment Firm

Overview

Great Bay Bio is a high-tech company developing blue ocean biopharmaceuticals with a digital CMC platform.

Announced Date

Sep 13, 2022

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

Tiger Jade Capital

Tiger Jade Capital

Tiger Jade Capital is a early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

6

Investor Name
Participant InvestorZhongjing Capital
Participant InvestorAlon Capital Ltd
Participant InvestorAlibaba Entrepreneurs Fund
Participant InvestorGobi Partners
Participant InvestorVectr

Round Details and Background

Great Bay Bio raised $15000000 on 2022-09-13 in Series A

Great Bay Bio is a high-tech company developing blue ocean biopharmaceuticals with a digital CMC platform.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 13, 2020
Convertible Note - Great Bay Bio
-2.5M
Dec 01, 2021
Series A - Great Bay Bio
4-10.0M
Jan 01, 2021
Seed Round - Great Bay Bio
1-undefined
Sep 13, 2022
Series A - Great Bay Bio
7-15.0M

Recent Activity

There is no recent news or activity for this profile.